Ultraselective conventional transarterial chemoembolization: When and how?
- Author:
Shiro MIYAYAMA
1
Author Information
- Publication Type:Review
- Keywords: Chemoembolization, Therapeutic; Hepatocellular carcinoma; Iodized oil; Gelatin sponge, Absorbable; Conebeam computed tomography
- MeSH: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Drainage; Gelatin; Gelatin Sponge, Absorbable; Hemodynamics; Hepatic Artery; Humans; Iodized Oil; Necrosis; Porifera; Portal Vein
- From:Clinical and Molecular Hepatology 2019;25(4):344-353
- CountryRepublic of Korea
- Language:English
- Abstract: Ultraselective conventional transarterial chemoembolization (cTACE), defined as cTACE at the most distal portion of the subsubsegmental hepatic artery, is mainly performed for hepatocellular carcinoma (HCC) ≤5 cm. Distal advancement of a microcatheter enables injection of a larger volume of iodized oil into the portal vein in the limited area under non-physiological hemodynamics. As a result, the reversed portal flow into the tumor through the drainage route of the tumor that occurs when the hepatic artery is embolized is temporarily blocked. By adding gelatin sponge slurry embolization, both the hepatic artery and portal vein are embolized and not only complete necrosis of can be achieved. Ultraselective cTACE can cure small HCCs including less hypervascular tumor portions and replace surgical resection and radiofrequency ablation in selected patients.
